Cite
HARVARD Citation
Mizukami, T. et al. (n.d.). Significance of FGF9 gene in resistance to anti‐EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti‐EGFR therapies. Molecular carcinogenesis. 56 (1), pp. 106-117. [Online].